Meanwhile , our study also demonstrated that the mean eGFR levels in LAM add-on group was decreased from 99.6 8.71 at baseline to 86.4 9.83 at the end of 48 weeks , which was significantly higher than that in the ETV monotherapy group ( P < 0.05 ) .